<DOC>
	<DOCNO>NCT02608489</DOCNO>
	<brief_summary>The purpose study determine whether 3 % diquafosol 0.1 % sodium hyaluronate effective safe treatment patient dry eye cataract surgery .</brief_summary>
	<brief_title>Clinical Effects Safety 3 % Diquafosol After Cataract Surgery</brief_title>
	<detailed_description>Study group protocol : This prospective open-label randomize study . All patient give full explanation study , write informed consent obtain participant . The study protocol adhere tenet Declaration Helsinki . The Institutional Review Board Ethics Committee , Soonchunhyang University Seoul Hospital , approve study ( SCHUH 2013-12-012 ) . Patients randomly allocate diquafosol group ( D group ) hyaluronate group ( H group ) use simple unrestricted randomization method controller . The D group use 3 % diquafosol tetrasodium ophthalmic solution ( Diquas® ; Santen Pharmaceutical Co. , Ltd. , Osaka , Japan ) six time day H group use 0.1 % sodium hyaluronate ophthalmic solution ( Hyalein® ; Santen Pharmaceutical Co. , Ltd. , Osaka , Japan ) six time day . Both group instill eye drop postoperative day 1 postoperative week 12 . Participants : Consecutive patient age 20-90 year bilateral unilateral cataract undergo uncomplicated phacoemulsification intraocular lens ( IOL ) implantation Soonchunhyang University Hospital January 2014 January 2015 enrol . The inclusion criterion patient mild moderate dry eye ( level 1 2 ) base dry eye severity scale adopt Dry Eye Workshop ( DEWS ) report use artificial tear occasionally1 , patient without mild blepharitis.18 The exclusion criterion presence complication cataract surgery cystoid macular edema , patient use topical eye drop regular basis , treatment history dry eye beyond artificial tear , ocular surgery within prior 6 month , contact lens wear , serious ocular surface disease ( e.g. , Sjögren 's syndrome , ocular pemphigoid , conjunctival scarring , chemical injury ) , lacrimal eyelid disease ( e.g. , moderate severe blepharitis18 ) , use concomitant medication could cause dry eye ( e.g. , antihistamine , antidepressant , decongestant , anticholinergic drug ) , allergy study medication . Objective subjective clinical assessment dry eye : All patient underwent ophthalmic examination preoperatively postoperatively order follow : uncorrected distant visual acuity ( UDVA ) test , ocular surface disease index ( OSDI ) questionnaire , Schirmer I test without anesthesia , change HOAs blinking , tear break-up time ( TBUT ) , corneal fluorescein staining , lissamine green ( LG ) conjunctival stain . Eyelid anterior chamber cell evaluate slit-lamp biomicroscopy ass presence blepharitis/meibomian gland plug intraocular inflammation . Routine postoperative examination schedule 1 week , 4 week , 12 week surgery . Efficacy safety evaluation : To evaluate efficacy two different eye drop , compare measurement two group throughout study period , follow-up , also compare pattern change group identify group recover earlier . evaluate safety two eye drop , include anterior chamber inflammation discontinuation eye drop due drug-related discomfort . Patients adverse event want stop use eye drop exclude study , patient include safety evaluation . Surgical procedure : A 2.8 mm clear corneal incision make location steep corneal astigmatism axis . A standard phacoemulsification technique use topical anesthesia 2 % lidocaine . A foldable IOL implant capsular bag . There suture corneal incision site . Patients receive moxifloxacin ( Vigamox ; Alcon , Fort Worth , TX ) , preservative-free formulation , rimexolone ( Vexol ; Alcon ) , contain 0.01 % BAK , four time day surgery 4 week . Statistical analysis : For statistical analysis , UDVA convert Snellen logMAR value . Baseline data compare group use Mann-Whitney U-test , Fisher 's exact test , linear mixed model adjust inter-eye correlation , age , sex . In addition , another mixed model use compare measurement data two group consider correlation eye patient follow-up . To obtain overall comparison treatment response throughout study period consider two level correlation subject follow-up , bivariate generalize linear mixed ( GLM ) model asymmetric random effect use . In last step , bivariate GLM model also use identify pattern change measure data throughout study period . The intergroup differences adverse event analyze use Fisher 's exact test . SPSS software ( version 21 , SPSS , Inc. , Chicago , IL ) use statistical analysis , P &lt; .05 take indicate statistical significance .</detailed_description>
	<mesh_term>Cataract</mesh_term>
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Capsule Opacification</mesh_term>
	<mesh_term>Hyaluronic Acid</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Bilateral unilateral cataract undergo phacoemulsification intraocular lens ( IOL ) implantation Soonchunhyang University Hospital January 2014 January 2015 Patients mild moderate dry eye ( level 1 2 ) base dry eye severity scale adopt Dry Eye Workshop ( DEWS ) report use artificial tear occasionally Presence complication cataract surgery cystoid macular edema Patients use topical eye drop regular basis Treatment history dry eye beyond artificial tear Any ocular surgery within prior 6 month Contact lens wear Serious ocular surface disease ( e.g. , Sjögren 's syndrome , ocular pemphigoid , conjunctival scarring , chemical injury ) Eyelid lacrimal disease Use concomitant medication could cause dry eye allergy study medication</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>